Kroger has been searching for a new CEO for nearly a year following the abrupt resignation of Rodney McMullen. The extended search contrasts with rivals such as Walmart and Target, which recently had ...

ElevenLabs co-founder and CEO Mati Staniszewski says voice is becoming the next major interface for AI – the way people will increasingly interact with machines as models move beyond text and screens.

GameSpot may get a commission from retail offers. The Walt Disney Company has announced that Josh D'Amaro--widely considered to win the job as the company's next CEO--is indeed the company's next CEO.

During a heated Senate hearing Tuesday on Netflix's proposed deal with Warner Bros. Entertainment, Sen. Josh Hawley, R-Mo., pressed the streaming platform's CEO on a recent statistic from a ...

A disgruntled ex-CEO locked his former video game studio out of its own website, knocked employees offline and triggered more than $1 million in alleged losses — then put the domain up for sale for $6 ...

D’Onofrio will take over for Lewis just days after the company's mass layoffs, which resulted in one-third of its staff being let go and the sports department being eliminated in full. By Lexi Carson, ...

Washington Post CEO and publisher Will Lewis has tendered his resignation, according to reports. Matt Viser, the Post's White House bureau chief, shared a screenshot of the email that newsroom staffed ...

Every January, YouTube’s CEO publishes a letter outlining where the platform is headed. In most years, these updates read like a product roadmap. Neal Mohan’s 2026 letter reads more like a strategic ...

Luke Miels had only been at the helm of GSK for 20 days before he signed off on his first multibillion-dollar buyout, and the CEO is clear on what else will attract his interest. “The basic framework ...

Disney's stock hasn't performed well in the last several years and is down 40% in the past five years. Bob Iger returned as CEO in 2022 after the board of directors fired Bob Chapek. Iger previously ...

Eli Lilly CEO Dave Ricks said upcoming Medicare coverage of obesity drugs could be a major catalyst for the launch of the company's closely watched experimental obesity pill, orforglipron. The launch ...